article thumbnail

Advances in Early Diagnosis

Healthcare IT Today

Nutromics’s measurement solution will be available commercially in 2028. This diagnostic tool is a big advance, and won FDA approval in 2022. Having completed their clinical study, Cordio Medical is submitting the app for FDA approval. They plan many other applications for the Nutromics patch. This can save lives.

Doctors 91
article thumbnail

A Step-by-step guide to Medical Device Quality System Management

Dot Compliance

The two most relevant quality regulations for medical device manufacturers are the FDA 21 CFR Part 820 and the ISO 13485:2016. The QMS supports the manufacturers, leading to ISO confirmation and FDA compliance. The FDA 21 CFR Part 820 is the mandatory standard for medical devices distributed in the US.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

Hall Render

On September 29, 2023, the Food and Drug Administration (“FDA”) announced the issuance of a Notice of Proposed Rulemaking (the “Proposed Rule”) to expand the FDA’s regulatory scope over in vitro diagnostics products (“IVDs”) to specifically address Laboratory Developed Tests (“LDTs”).

FDA 40
article thumbnail

5 Necessary Steps for Building a Risk Assessment Framework

Dot Compliance

between 2021, and 2028. FDA’s Safer Technologies Program (SteP) for Medical Devices. The Safer Technologies Program (SteP) is a new, voluntary FDA program for medical devices and device-led combination products that enhance the safety of treatments for non-threatening conditions. It’s currently worth $7.7

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

Of interest is a reference to the FDA’s draft document “Computer Software Assurance for Production and Quality System Software,” which was recently published on 13 September 2022. PCPC looks forward to working with the FDA and key stakeholders to implement this important legislation.

article thumbnail

Connected Medical Devices—the Next Target for Ransomware Attacks

Healthcare IT Today

Food and Drug Administration (FDA) has recognized the problem and issued multiple guidance documents over the years—as recently as this March —to ensure the cybersecurity of medical devices. Although none of the FDA recommendations are legally enforceable, device manufacturers no longer have a choice but to comply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

As in the past, the PCPC stands ready to collaborate with the FDA and other stakeholders to ensure any reorganization enables the beauty and personal care industry to continue to provide innovative, safe, and effective products while maintaining consumer trust. The PCPC looks forward to working with FDA Chief Scientist Namandjé Bumpus, Ph.D.,

FDA 40